AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Odyssey Math Tuition, a tuition agency in Singapore, has launched a dedicated JC 1 math tuition elearning course to support ...

Recursion Pharmaceuticals ( RXRX 3.12%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious "techbio" company positions itself for its next phase of AI drug discovery.

Dh120b group now spans energy, food, logistics, mining, apparel, media, mobility, beauty ADX-listed IHC announced plans to merge its flagship portfolio companies, 2PointZero, Multiply Group, and ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...

Aritzia could be a ten-bagger, a scalable “everyday luxury” brand growing fast in the U.S. with strong margins and repeat customers. Aritzia’s powerful brand and U.S. expansion create scalable growth ...

This study offers a valuable advance for neuroscience by extending a visualization tool that enables intuitive assessment of how dendritic and synaptic currents shape the output of neurons. The ...